Differences between the N-glycans of human serum erythropoietin and recombinant human erythropoietin.

نویسندگان

  • Patrick L Storring
  • C-T Yuen
چکیده

The differences between the N-glycans of human erythropoietin (hEPO), extracted from serum, and recombinant human erythropoietin (rhEPO) reported by Skibeli et al1 have received attention in the editorials of 2 other journals. One suggested that these differences might be involved in the etiology of the autoimmune pure red cell aplasia found in some patients treated with rhEPO.2 The other suggested that these differences might form the basis for a test to detect the doping of athletes with rhEPO.3 A review of the data of Skibeli et al, however, indicates that the differences they have reported between the N-glycans of hEPO and rhEPO are not consistent with the differences between the physicochemical properties of these EPOs found in other laboratories. This discrepancy may be a consequence of the effects on the N-glycans of hEPO of the conditions used by Skibeli et al to extract hEPO from serum in order to compare it with unextracted rhEPO. Skibeli et al reported that hEPO lacked the tetra-acidic (tetrasialylated) N-glycans found in the rhEPOs, and was also lower in its content of tri-acidic N-glycans.1 These findings are summarized in their Table1,1 which also permits comparison of the N-glycan charges of different EPOs, as calculated, for example, by the method of Hermentin et al.4 This suggests that the total negative charge of the N-glycans of hEPO is 70% that of the rhEPOs, and implies that hEPO is less acidic than the rhEPOs. Thus the sialic acid residues of the N-glycans of EPO represent up to 12 of a possible total of 14 sialic acid residues in EPO, and make a major contribution to the net negative charge of EPO, as indicated by the fact that the pI of intact EPO is in the range of about 2.5 to 4.0,5 and the pI of desialylated EPO is about 8.5.6 However, other studies have consistently shown hEPO to be more acidic than rhEPO,7-9 and, indeed, this is the basis for an established test for doping.9 The discrepancy between the findings of Skibeli et al and those of others is probably due to the conditions used to extract the hEPO from serum to compare it with unextracted rhEPOs. Although the data in Figure 8 of Skibeli et al is said to demonstrate “the similarity of sugar profiles from rhEPO with or without a beadextraction step,” comparisons of the areas under the 2 elution profiles indicates that the extraction procedure has reduced the recovery of all oligosaccharides with elution times of 60 minutes or more, representing triand tetrasialylated N-glycans, and has increased the relative recovery of most of the neutral, monoand di-sialylated N-glycans.1 This effect of the extraction procedure probably represents some desialylation of the N-glycans of EPO, since the 20min-treatment with 10mmol/l HCl, used to dissociate the antibody-bound EPO, is also commonly used, albeit at 80°C rather than ambient temperature, for the quantitative desialylation of N-glycans.10

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Effects of Recombinant Human Erythropoietin (rHuEpo) on the Blood Cells and Hematopoiesis in Spleen of Rats

Recombinant human erythropoietin is a glycoprotein hormone that stimulates erythropoiesis. In clonogenic assays of hematopoietic progenitors, high concen-trations of erythropoietin (Epo) increase CFU-E and diminish the number of granulocytes formed per culture plate. Fetal progenitors are more sensitive to these effects of Epo than progenitors from adults. We administered doses 50, 100, 200 IU/...

متن کامل

The Effects of Recombinant Human Erythropoietin (rHuEPO) on Antihuman Lymphocyte Antibodies Titer in Sensitized Rats

Erythropoietin (EPO) was first known as a factor for red blood cell proliferation and differentiation. Recent studies show the effects of EPO on immune system. In this study the antihuman leukocyte antibody (anti-HLA) titer were determined in five groups of rats, which had been sensitized with human lymphocyte. Also, the effects of stimulation's frequency and dose of recombinant human erythropo...

متن کامل

Effects of Recombinant Human Erythropoietin Pretreatment on Anti-HLA Antibody Titer: A Preclinical Experience in Rats

Background: Erythropoietin (EPO) was first known as a factor for red blood cell proliferation and differentiation. New studies show the effects of EPO on immune system. Objective: In this study, the effects of pretreatment with recombinant human erythropoietin (rHuEPO) on the anti-human leukocyte antibody (anti-HLA) titer were determined. Methods: Three groups of rats were sensitized with human...

متن کامل

Evaluation of pH/buffering conditions effect on the optimization of Recombinant Human Erythropoietin expression in the methylotrophic yeast, Pichia pastoris

Expression of recombinant proteins and drugs in Pichia pastoris has been in development since the late 1980s and the number of recombinant proteins produced in P. pastoris has increased significantly in the past several years. Unlike bacteria, this strain is capable of producing complex proteins with post translational modifications such as correct folding, glycosylation, proteolytic maturation...

متن کامل

Recombinant Human Erythropoietin in Children with Solid Tumors and Chemotherapy-induced Anemia

Background: In patients undergoing chemotherapy for cancer, anemia is part of the progression of the disease. Considering the effects of anemia on quality of life of the patients, the prevention and treatment of chemotherapy-induced anemia is crucial. This study was aimed to evaluate the efficacy of recombinant human erythropoietin in reducing the need for blood transfusion in children with sol...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Blood

دوره 101 3  شماره 

صفحات  -

تاریخ انتشار 2003